"Circulating Cancer Cells / Macrophage HYbrid Cells in Patients With Sarcoma, Part 2"

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Leiomyosarcoma
Interventions
OTHER

Blood samples will be collected at different times.

"For patients with localized leiomyosarcoma, samples will be collected:~* At Baseline.~* Before surgery (for patients who have had neoadjuvant treatment (external radiotherapy and/or chemotherapy)).~* After surgery.~* At each control visit.~* At local or metastatic recurrence (or at 24 months post inclusion if no progression).~For patients with metastatic leiomyosarcoma, samples will be collected:~* At Baseline.~* At each therapeutic line.~* At progression (or at 24 months post inclusion if no progression)."

Trial Locations (1)

31059

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

All Listed Sponsors
collaborator

Fondation ARC

OTHER

lead

Institut Claudius Regaud

OTHER